Christopher J Coughlin - Net Worth and Insider Trading

Christopher J Coughlin Net Worth

The estimated net worth of Christopher J Coughlin is at least $12 Million dollars as of 2024-04-24. Christopher J Coughlin is the Director of Alexion Pharmaceuticals Inc and owns about 26,333 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $5 Million. Christopher J Coughlin is the Director of Allergan PLC and owns about 16,431 shares of Allergan PLC (AGN) stock worth over $3 Million. Christopher J Coughlin is also the Exec. Vice President and CFO of Tyco International PLC and owns about 42,975 shares of Tyco International PLC (TYC) stock worth over $2 Million. Besides these, Christopher J Coughlin also holds Centene Corp (CNC) , Dun & Bradstreet Corp (Dun Bradstreet Corp) . Details can be seen in Christopher J Coughlin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher J Coughlin has not made any transactions after 2022-04-29 and currently still holds the listed stock(s).

Transaction Summary of Christopher J Coughlin

To

Christopher J Coughlin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher J Coughlin owns 8 companies in total, including Prestige Consumer Healthcare Inc (PBH) , Alexion Pharmaceuticals Inc (ALXN) , and Karuna Therapeutics Inc (KRTX) among others .

Click here to see the complete history of Christopher J Coughlin’s form 4 insider trades.

Insider Ownership Summary of Christopher J Coughlin

Ticker Comapny Transaction Date Type of Owner
PBH Prestige Consumer Healthcare Inc 2020-08-04 director
ALXN Alexion Pharmaceuticals Inc 2020-05-14 director
KRTX Karuna Therapeutics Inc 2020-04-24 director
HOLX Hologic Inc 2016-03-02 director
PLXPQ PLx Pharma Winddown Corp 2014-03-12 director
JCI Johnson Controls International PLC 2007-06-29 Exec. VP and CFO
IPG The Interpublic Group of Companies Inc 2003-06-16 director & COO
CNC Centene Corp 2022-04-29 director

Christopher J Coughlin Latest Holdings Summary

Christopher J Coughlin currently owns a total of 5 stocks. Among these stocks, Christopher J Coughlin owns 26,333 shares of Alexion Pharmaceuticals Inc (ALXN) as of April 30, 2018, with a value of $5 Million and a weighting of 41.62%. Christopher J Coughlin owns 16,431 shares of Allergan PLC (AGN) as of September 6, 2018, with a value of $3 Million and a weighting of 27.47%. Christopher J Coughlin also owns 42,975 shares of Tyco International PLC (TYC) as of February 21, 2006, with a value of $2 Million and a weighting of 16.97%. The other 2 stocks Centene Corp (CNC) , Dun & Bradstreet Corp (Dun Bradstreet Corp) have a combined weighting of 13.94% among all his current holdings.

Latest Holdings of Christopher J Coughlin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ALXN Alexion Pharmaceuticals Inc 2018-04-30 26,333 182.50 4,805,773
AGN Allergan PLC 2018-09-06 16,431 193.02 3,171,512
TYC Tyco International PLC 2006-02-21 42,975 45.59 1,959,230
CNC Centene Corp 2022-04-29 15,865 75.83 1,202,964
Dun Bradstreet Corp Dun & Bradstreet Corp 2015-11-06 15,857 25.65 406,732

Holding Weightings of Christopher J Coughlin


Christopher J Coughlin Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher J Coughlin has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the acquisition of 10,000 shares on April 30, 2018, which cost Christopher J Coughlin around $1 Million.

According to the SEC Form 4 filings, Christopher J Coughlin has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the acquisition of 10,000 shares on September 6, 2018, which cost Christopher J Coughlin around $2 Million.

According to the SEC Form 4 filings, Christopher J Coughlin has made a total of 0 transactions in Tyco International PLC (TYC) over the past 5 years. The most-recent trade in Tyco International PLC is the acquisition of 2,387 shares on February 21, 2006, which cost Christopher J Coughlin around $255,400.

More details on Christopher J Coughlin's insider transactions can be found in the Insider Trading History of Christopher J Coughlin table.

Insider Trading History of Christopher J Coughlin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher J Coughlin Trading Performance

GuruFocus tracks the stock performance after each of Christopher J Coughlin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher J Coughlin is 4.27%. GuruFocus also compares Christopher J Coughlin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher J Coughlin within 3 months outperforms 5 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Christopher J Coughlin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Christopher J Coughlin

Average Return

0.45%

Average return per transaction

Outperforming Transactions

43%

3 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 3.48 4.27 -5.45 0.45 0.79 -1.59
Relative Return to S&P 500(%) 2.11 3.71 -6.98 -6.77 -6.36 -4.18

Christopher J Coughlin Ownership Network

Ownership Network List of Christopher J Coughlin

No Data

Ownership Network Relation of Christopher J Coughlin


Christopher J Coughlin Owned Company Details

What does Prestige Consumer Healthcare Inc do?

Who are the key executives at Prestige Consumer Healthcare Inc?

Christopher J Coughlin is the director of Prestige Consumer Healthcare Inc. Other key executives at Prestige Consumer Healthcare Inc include Senior VP Quality & Regulatory Mary Beth Fritz , other: EVP & Marketing & Sales Adel Mekhail , and See Remarks William P'pool .

Prestige Consumer Healthcare Inc (PBH) Insider Trades Summary

Over the past 18 months, Christopher J Coughlin made no insider transaction in Prestige Consumer Healthcare Inc (PBH). Other recent insider transactions involving Prestige Consumer Healthcare Inc (PBH) include a net sale of 23,979 shares made by Mary Beth Fritz , a net sale of 54,661 shares made by William P'pool , and a net sale of 49,937 shares made by Adel Mekhail .

In summary, during the past 3 months, insiders sold 77,758 shares of Prestige Consumer Healthcare Inc (PBH) in total and bought 0 shares, with a net sale of 77,758 shares. During the past 18 months, 285,483 shares of Prestige Consumer Healthcare Inc (PBH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 285,483 shares.

Prestige Consumer Healthcare Inc (PBH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Prestige Consumer Healthcare Inc Insider Transactions

No Available Data

Christopher J Coughlin Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher J Coughlin. Currently GuruFocus does not have mailing address information for Christopher J Coughlin.

Discussions on Christopher J Coughlin

No discussions yet.